National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

Statutory Rules

1973 No. 57

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1972. *

WHEREAS it is provided by sub-section (4.) of section 101 of the National Health Act 1953-1972 that a drug or medicinal preparation that was not a pharmaceutical benefit under the National Health Act 1953-1958 immediately before the commencement of that sub-section shall not be prescribed as a pharmaceutical benefit in accordance with section 85 of that Act unless the Pharmaceutical Benefits Advisory Committee has recommended to the Minister that it be so prescribed:

AND WHEREAS that Committee has recommended to the Minister that the following drugs and medicinal preparations be prescribed as pharmaceutical benefits under section 85 of the National Health Act 1953-1972, namely, the drugs and medicinal preparations specified in the Third Schedule to the National Health (Pharmaceutical Benefits) Regulations, as amended by the following Regulations, that had not previously been prescribed as pharmaceutical benefits:

NOW THEREFORE I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1972.

Dated this fifteenth day of March, 1973.

PAUL HASLUCK

Governor-General.

By His Excellency's Command,

D. EVERINGHAM

Minister of State for Health.

Amendments of the National Health (Pharmaceutical Benefits) Regulations  

Commencement.

1. These Regulations shall come into operation on the first day of April, 1973.

First Schedule.

2. The First Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 1.

Second Schedule.

3. The Second Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 2.

Third Schedule.

4. The Third Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 3.

Fourth Schedule.

5. The Fourth Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 4.

Fifth Schedule.

6. The Fifth Schedule to the National Health (Pharmaceutical Benefits) Regulations is amended as set out in Schedule 5.

* Notified in the Commonwealth Gazette on 22 March 1973.

  Statutory Rules 1960, No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102; 1961, Nos. 59 and 137; 1962, Nos. 34, 101 and 114; 1963, Nos. 34, 69 and 107; 1964, Nos. 12, 57 and 135; 1965, Nos. 51, 151 and 152; 1966, Nos. 80 and 144; 1967, Nos. 67, 116 and 158; 1968, Nos. 44, 76, 88 and 146; 1969, Nos. 44, 107 and 185; 1970, Nos. 39, 94, 119 and 186; 1971, Nos. 44, 101, 136 and 154; 1972, Nos. 32, 121 and 205; and 1973. No. 15.

SCHEDULE 1 Regulation 2

Amendments of the First Schedule to the National Health (Pharmaceutical Benefits) Regulations

1. After item 8 insert the following item:—

“ 8a. Alprenolol Hydrochloride ”.

2. After item 53 insert the following item:—

“ 53a. Carbamazepine ”.

3. After item 69 insert the following item:—

“ 69a. Chlormerodrin (197Hg) Injection ”.

4. After item 118 insert the following item:—

“ 118aa. Deoxycortone Acetate Implants ”.

5. After item 154 insert the following item:—

“ 154a. Diphenoxylate Hydrochloride ”.

6. After item 163 insert the following items:—

“ 163a. Dydrogesterone

163b. Dydrogesterone Tablets ”.

7. After item 172 insert the following item:—

“ 172a. Ether Solvent ”.

8. After item 214 insert the following item:—

“ 214a. Human Antihaemophilic Fraction ”.

9. After item 220 insert the following item:—

“ 220a. Hydroxyprogesterone Hexanoate ”.

10. After item 226 insert the following item:—

“ 226a. Indomethacin ”.

11. After item 230 insert the following item:—

“ 230a. Iodinated (125 I) Human Serum Albumin Injection ”.

12. After item 246 insert the following item:—

“ 246a. Levodopa ”.

13. After item 270 insert the following items:—

“ 270a. Melphalan

270b. Melphalan Injection ”.

14. After item 289 insert the following item:—

“ 289a. Methylcellulose 450 ”.

15. After item 301 insert the following item:—

“ 301a. Metyrapone ”.

16. After item 316 insert the following item:—

“ 316a. Nitrazepam ”.

17. After item 345 insert the following items:—

“ 345a. Pentagastrin

345b. Pentagastrin Injection ”.

18. After item 414 insert the following item:—

“ 414aa. Rubella Vaccine (Live Attenuated) ”.

19. After item 416 insert the following items:—

“ 416a. Slow Lithium Carbonate Tablets

416b. Slow Orphenadrine Citrate Tablets ”.

20. Omit item 418.

21. After item 444 insert the following item:—

“ 444a. Sorbitol Injection ”.

22. After item 492 insert the following item:—

“ 492a. Trimipramine Maleate ”.

SCHEDULE 2 Regulation 3

Amendments of the Second Schedule to the National Health (Pharmaceutical Benefits) Regulations

1. After item 8 insert the following item:—_
“ 8a	Aminocaproic Acid ..............................................	— ”.
2. Omit item 70, substitute the following item:—
“ 70	Doxycycline Hydrochloride ..............................................	— ”.
3. After item 80 insert the following item:—
“ 80a	Fluoclorolone Acetonide ..............................................	— ”.
4. After item 81 insert the following items:—
“ 81a	Fluocinolone Acetonide ..............................................	—
8lb	Fluocortolone Hexanoate ..............................................	Fluocortolone Pivalate with Fluocortolone Hexanoate
81c	Fluocortolone Pivalate ..............................................	Fluocortolone Hexanoate with Fluocortolone Pivalate ”.
5. After item 82 insert the following item:—
“ 82aa	Flurandrenolone ..............................................	— ”.
6. Omit item 108, substitute the following item:—
“ 108	Magnesium Chloride ..............................................	Sodium Chloride with Ammonium Chloride, Potassium Chloride and Magnesium Chloride
Sodium Chloride with Potassium Chloride, Sodium Lactate and Magnesium Chloride
Sodium Chloride with Sodium Acetate, Sodium Gluconate, Potassium Chloride and Magnesium Chloride ”.
7.After item 112 insert the following item:—
“ 112aa	Medrysone ..............................................	— ”.
8. Omit item 114, substitute the following item:—
“ 114	Methacycline Hydrochloride..............................................	— ”.
9. After item 180 insert the following item:—
“ 180a	Sodium Acetate ..............................................	Sodium Chloride with Potassium Chloride, Magnesium Chloride, Sodium Gluconate and Sodium Acetate ”.
10. After item 181 insert the following item:—
“ 181A	Sodium Gluconate ..............................................	Sodium Chloride with Sodium Acetate, Potassium Chloride, Magnesium Chloride and Sodium Gluconate ”.
11. After item 195 insert the following item:—
“ 195a	Terbutaline Sulphate ..............................................	— ”.

SCHEDULE 3 Regulation 4

Amendments of the Third Schedule to the National Health (Pharmaceutical Benefits) Regulations

1. Omit item 17.

2. Omit item 28.

3. Omit item 64.

4. Omit item 70.

5. Omit item 100.

6. After item 120a insert the following item:—

“ 121. Doxepin Hydrochloride ”.

7. Omit item 122.

8. After item 138 insert the following item:—

“ 138a. Fluclorolone Acetonide ”.

9. Omit item 143, substitute the following item:—

“ 143. Flurandrenolone ”.

10. Omit item 149.

11. Omit item 167.

12. After item 172 insert the following item:—

“ 172a. Ibuprofen ”.

13. Omit item 173.

14. Omit item 198.

15. Omit item 202.

16. After item 215 insert the following item:—

“ 215a. Medrysone ”.

17. Omit item 216.

18. Omit item 221.

19. Omit item 233.

20. Omit item 242.

21. Omit item 275a.

22. Omit item 276.

23. Omit item 301.

24. Omit item 313.

25. Omit item 327.

26. Omit item 331.

27. Omit item 337a, substitute the following item:—

“ 337a. Sodium Gluconate ”.

28. Omit item 344.

29. Omit item 356.

30. After item 366 insert the following item:—

“ 366a. Terbutaline Sulphate ”.

31. Omit item 390.

32. Omit item 391.

33. Omit item 396.

SCHEDULE 4 Regulation 5

Amendments of the Fourth Schedule to the National Health (Pharmaceutical Benefits) Regulations

1. After item 19 insert the following item:—

“ 19A, Hypromellose 4500 ”.

2. After item 20 insert the following item:—

“ 20a. Methylcellulose 450 ”.

3. After item 24 insert the following item:—

” 24a. Solvent Ether ”.

SCHEDULE 5 Regulation 6

Amendments of the Fifth Schedule to the National Health (Pharmaceutical Benefits) Regulations

1. Omit from item 6 the words:—

“ Alprenolol Hydrochloride Injection ” (in the second column),

substitute the words:—

“ Alprenolol Injection, B.P.".

2. Omit item 7, substitute the following item:—

“ 7	Alprenolol Tablets, B.P........	With the written authority of the Director-General— Idiopathic hypertrophic subaortic stenosis Right ventricular outflow tract obstruction Dissecting aneurysm, aortic The treatment of angina in a patient who is frequently disabled by attacks of angina, in whom no evidence of cardiac failure is found and whose attacks of angina do not respond to other therapeutic agents except other beta-adrenergic receptor blocking agents  Serious arrhythmias Thyrotoxicosis Treatment of severe hypertensive disease where other treatment has proved ineffective ”.
3. Omit item 9, substitute the following item:—
“ 9	(1) Aminocaproic Acid, B.P. (2) Aminocaproic Acid injection, B.P.	Any disease or condition in a patient receiving treatment in or at an approved hospital ”.
4. Omit item 22, substitute the following item:—
“ 22	Betamethasone Acetate with Betamethasone Injection	Intra-articular use Uveitis With the written authority of the Director-General, pre-operative and post-operative prophylactic therapy for those patients undergoing or recently subjected to steroid therapy ”.
5. Omit item 27, substitute the following item:—
“ 27	Carbamazepine Tablets, B.P.	Epilepsy Trigeminal neuralgia ”.

6. Insert in item 28, before the words:—

“ With the written authority of the Director-General,” (in the third column),

the words:—

“ Any disease or condition in a patient receiving treatment in or at an approved hospital ”.

7. Insert in item 31, before the words:—

“ With the written authority of the Director-General,” (in the third column),

the words:—

“ Any disease or condition in a patient receiving treatment in or at an approved hospital ”.

Schedule 5—continued

8. Omit item 41a.

9. Omit item 42, substitute the following item:—

“ 42	(1) Cloxacillin Sodium, B.P.	Any disease or condition in a patient receiving
(2) Cloxacillin Capsules, B.P.	treatment in or at an approved hospital
(3) Cloxacillin Sodium, B.P., with Purified Water, B.P.	With the written authority of the Director-General— Serious infections where bacteriological evidence confirms the presence of penicillinase-producing staphylococci Osteomyelitis ”.

10. Omit item 49a.

11. Omit item 51, substitute the following item:—

“ 51	Deoxycortone Acetate, B.P. ..	Adrenal cortical hypofunction ”.
12. Omit item 56, substitute the following item:—
“ 56	Diazoxide .. ..	Hypertensive crisis ”.
13. Omit item 63a, substitute the following item:—
“ 63a	Dipyridamole .. ..	Supplementing anticoagulants in— Biopsy proven glomerulonephritis Microangiopathic renal disease Renal allograft Patients with cardiac prosthesis ”.

14. Omit item 64.

15. Omit from item 64a the words:—

“ Doxycycline Hyclate Suspension” (in the second column), substitute the words:—

“ Doxycycline Hydrochloride Suspension ”.

16. Omit item 72, substitute the following item:—

“ 72	Fludrocortisone Tablets, B.P.	Adrenal conical hypoplasia including Addison's disease Orthostatic hypotension Total adrenalectomy ”.
17. Omit item 84, substitute the following item:—
“ 84	Glucose Indicator—Blood ..	Diabetes mellitus, where blood sugar levels cannot be determined to be within a satisfactory range by urine testing ”.
18. Omit from item 94 the words:— “ Hydroxyprogesterone Caproate ” (in the second column), substitute the words:—
“ Hydroxyprogesterone Injection, B.P.”.
19. After item 95 insert the following item:—
“ 95a	Ibuprofen .. ..	Rheumatoid arthritis where salicylates are contra-indicated or ineffective Osteoarthritis where salicylates are contra-indicated or ineffective ”.
20. Omit item 98, substitute the following item:—
“ 98	Insect Allergen Extract—Honey Bee	Severe constitutional reaction to bee stings ”.
21. Omit item 99, substitute the following item:—
“ 99	Insect Allergen Extract—Jumper Ant	Severe constitutional reaction to jumper ant stings ”.
22. Omit item 100, substitute the following item:—
“ 100	Insect Allergen Extract—Paper Wasp	Severe constitutional reaction to paper wasp stings ”.
23. Omit item 103, substitute the following item:—
“ 103	Kanamycin Sulphate Injections	Infections where positive bacteriological evidence confirms that Kanamycin Sulphate is the most appropriate antibiotic Septicaemia, including suspected septicaemia ”.

Schedule 5—continued

24. Omit item 106, substitute the following item:—

“ 106	Levodopa Capsules, B.P............	With the written authority of the Director-General, of
Levodopa Tablets, B.P.	treatment Parkinson's disease ”.

25. Omit item 108, substitute the following item:—

"108	Lincomycin Capsules, B.P.........	Gram positive coccal infections where these cannot
Lincomycin Hydrochloride, B.P.	be safely and effectively treated with a penicillin Osteomyelitis ”.
Lincomycin Injection, B.P.

26. Omit item 119, substitute the following item:—

“ 119 Melphalan Tablets, B.P............................................... Treatment of malignant neoplasia ”

27. Omit from item 120a the words:—

“ Methacycline Suspension ” (in the second column),

substitute the words:—

“ Methacycline Hydrochloride, B.P.”.

28. Omit item 128, substitute the following item:—

“ 128 Metyrapone Capsules, B.P................................................. Any disease or condition in a patient receiving treatment in or at an approved hospital ”.

29. Omit item 152, substitute the following item:—

“ 152	(1) Pericyazine Mesylate.................................................	Any disease or condition in a patient receiving
(2) Pericyazine	treatment in or at an approved hospital Major psychoses, including— Major organic psychoses Manic psychoses Paranoid states Schizophrenia Hereditary chorea (Huntington’s) Malignant neoplasia (late stage) Radiation sickness Severe conduct disorders in patients who have not attained the age of sixteen years ”.

30. Omit item 182, substitute the following item:—

“ 182 Senna Tablets, B.P Any disease or condition in a pensioner ”.

31. Omit item 188.

32. Omit item 199a, substitute the following item:—

“ 199a Thiopropazate Hydrochloride With the written authority of the Director-General— Hereditary chorea (Huntington’s) Oral dyskinesia Phenothiazine-induced choreo-athetosis ”.

33. Omit item 204, substitute the following item:—

“ 204	(1) Trifluoperazine Hydrochloride, B.P.	Any disease or condition in a patient receiving treatment in or at an approved hospital
(2) Trifluoperazine Tablets, B.P.	Major psychoses including— Major organic psychoses Manic psychoses Paranoid states Schizophrenia Hereditary chorea (Huntington’s) Malignant neoplasia (late stage) Radiation sickness Severe conduct disorders in patients who have not attained the age of sixteen years ”.

34. Omit item 212, substitute the following item:—

“ 212 ‘ ZOFF ’................................ Ileostomy or colostomy conditions For use with surgical appliances ”.